实施状细胞疾病的综合风险调整成本效益模型:一个案例研究
Marlon Graf1, Joris Kleintjens2, Md Tahsin Hasan1
1Precision AQ, Bethesda, MD, USA.
概括
综合风险调整成本效益 (GRACE) 方法增强了状细胞疾病基因疗法的成本效益分析. 这种方法揭示了这些治疗方法具有成本效益,改善了社会价值和资源分配.
科学领域:
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
- 医疗技术评估 医疗技术评估
背景情况:
- 传统的成本效益分析 (CEA) 可能低估了针对状细胞病等严重疾病的创新疗法.
- 社会价值考虑的因素超出了直接成本,包括生活质量和不确定性.
研究的目的:
- 使用一般化风险调整成本效益 (GRACE) 方法量化治愈状细胞病的社会价值.
- 为了根据疾病严重程度,治疗结果的不确定性和预期寿命的质量调整成本效益计算.
主要方法:
- 使用GRACE框架重新校准了状细胞疾病基因疗法 (lovo-cel, exa-cel) 的健康技术评估.
- 通过根据疾病严重程度和治疗不确定性调整支付意愿门,修改了CEA.
主要成果:
- 在GRACE的实施下,lovo-cel和exa-cel的增量成本效益比率降低了6%.
- 在GRACE下,支付意愿门增加了大约50%.
- 从直接付款人和社会角度来看,Lovo-cel和exa-cel被认为是具有成本效益的.
结论:
- 格雷斯 (GRACE) 方法提供了对创新疗法的社会价值更全面的估计.
- 在医疗保健中,GRACE促进了更高效,更公平的资源分配.
- 这项研究倡导将GRACE元素纳入健康技术评估中,以便更广泛地接受改变生活的治疗方法.
更多相关视频
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
10.0K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.7K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
185
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185
Methods of Documentation VI: Case Management Model
635
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
635
Pharmacokinetic Models: Comparison and Selection Criterion
155
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
155
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Kaplan-Meier Approach
284
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
284
Multiple Allele Traits
35.0K
The Concept of Multiple Allelism
35.0K
